Bristol-Myers Squibb (BMY) Misses Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $57.13 +0.40%
EPS Growth %: +10.3%
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +10.3%
Financial Fact:
Provision for income taxes: 344M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance
- Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
